Abnormal amyloid PET usually represents intermediate/high Alzheimer's disease neuropathologic change
INTRODUCTION: Alzheimer's disease neuropathologic change (ADNC) classification identifies not/low and intermediate/high levels of neuropathology. Our goal was to assess how frequently a positive amyloid positron emission tomography (PET) scan indicates not/low ADNC and whether this autopsy finding can occur >10 years after a positive amyloid PET. METHODS: Participants with positive amyloid PET scans were categorized by levels of ADNC at autopsy, grouped by time from initial positive amyloid PET to time of death (<5 years, 5 to <10 years, or 10+ years). RESULTS: Among those with a positive amyloid PET scan, the majority had intermediate/high ADNC at autopsy (234/259, 90%). In the group with 10+ years between a positive amyloid PET and death (n = 39) not/low ADNC occurred in 3/39 (8%). DISCUSSION: Not/low ADNC is uncommon among those with positive amyloid PET scans. After 10+ years, it is possible but rare for a positive amyloid PET scan to represent an indolent state of neuropathology.
Authors
- D H Johnson
- Aivi T. Nguyen (ORCID: https://orcid.org/0000-0003-1809-9451)
- Miller MD
- Heather J. Wiste (ORCID: https://orcid.org/0009-0002-8833-2693)
- Petrice M. Cogswell
- Ronald C. Petersen
- Melissa E. Murray
- Bradley F. Boeve
- Clifford R. Jack
- Jay Pillai
- Kejal Kantarci
- Christopher G. Schwarz
- Val Lowe
- Prashanthi Vemuri
- David S. Knopman
- Jonathan Graff‐Radford
- Dennis W. Dickson
Institutions
- Mayo Clinic (US)
- Jacksonville College (US)
- Mayo Clinic in Florida (US)
Publication Details
- Journal
- Alzheimer s & Dementia
- Published
- 2026-05-01
- DOI
- https://doi.org/10.1002/alz.71449
- Primary Topic
- Dementia and Cognitive Impairment Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Foundation for the National Institutes of Health
- GHR Foundation